[(2R,4R,5S,6R)-6-ethyl-2-[(2R,3S,4R)-3-hydroxy-4-[(2R,3R,4E,6E,9R,10S,11S,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-2-methoxy-5-methyloxan-4-yl] (E)-4-amino-4-oxobut-2-enoate

Term ID

CHEBI:217336

Synonyms

[(2R,4R,5S,6R)-6-ethyl-2-[(2R,3S,4R)-3-hydroxy-4-[(2R,3R,4E,6E,9R,10S,11S,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-2-methoxy-5-methyloxan-4-yl] (E)-4-amino-4-oxobut-2-enoate

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: macrolide

macrolide Show first 5 Terms

Phenotype

Phenotype resulting from [(2R,4R,5S,6R)-6-ethyl-2-[(2R,3S,4R)-3-hydroxy-4-[(2R,3R,4E,6E,9R,10S,11S,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-2-methoxy-5-methyloxan-4-yl] (E)-4-amino-4-oxobut-2-enoate

Phenotype where environments contain [(2R,4R,5S,6R)-6-ethyl-2-[(2R,3S,4R)-3-hydroxy-4-[(2R,3R,4E,6E,9R,10S,11S,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-2-methoxy-5-methyloxan-4-yl] (E)-4-amino-4-oxobut-2-enoate

Phenotype modified by environments containing [(2R,4R,5S,6R)-6-ethyl-2-[(2R,3S,4R)-3-hydroxy-4-[(2R,3R,4E,6E,9R,10S,11S,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-2-methoxy-5-methyloxan-4-yl] (E)-4-amino-4-oxobut-2-enoate

Human Disease / Model Data

Citations